A man dressed in protective hazmat clothing treats the front porch of an apartment where a second person diagnosed with the Ebola virus resides in October 2014 in Dallas, Texas. Federal officials lifted a moratorium Tuesday on funding research that alters deadly viruses to make them more lethal or transmissible. (2014 file photo/Mike Stone/Getty Images)
© 2024 Blaze Media LLC. All rights reserved.
Research to make viruses more deadly can now be funded by the government
December 19, 2017
For the last three years, the government hasn’t been able to fund research that alters deadly viruses to make them more lethal or transmissible.
That changed Tuesday, as federal officials lifted a moratorium on funding of such research that was imposed in 2014, according to the New York Times.
What does this mean?
Twenty-one projects were halted when the moratorium went into effect. Out of those, 10 of them received exceptions to continue: five related to flu viruses, and five related to Middle East respiratory syndrome (MERS).
Scientists can now perform research on contagious viruses such as bird flu, SARS, or MERS, altering them to make them more dangerous (known as “gain of function” research) and learning about them to potentially create better vaccines.
There are some conditions:
- A scientific panel must determine that the benefits justify the risks
- Research must be done in a high-security lab
- The pathogen modified must pose a serious health threat
- The research must produce knowledge that would benefit humans
- There must be no safer way to do the research
Is this a good idea?
Depends on who you ask. Harvard epidemiologist Marc Lipsitch doesn’t think so.
Lipsitch said gain of function research has “given us some modest scientific knowledge and done almost nothing to improve our preparedness for pandemics, and yet risked creating an accidental pandemic.”
Proponents of the research say altering these viruses gives insight into how they could mutate to more easily infect humans, which could show scientists how to make more effective vaccines.
Want to leave a tip?
We answer to you. Help keep our content free of advertisers and big tech censorship by leaving a tip today.
Want to join the conversation?
Already a subscriber?
Aaron Colen
Aaron is a former staff writer for TheBlaze. He resides in Denton, Texas, and is a graduate of the University of Oklahoma where he earned his Bachelor of Arts in journalism and a Master of Education in adult and higher education.
more stories
Sign up for the Blaze newsletter
By signing up, you agree to our Privacy Policy and Terms of Use, and agree to receive content that may sometimes include advertisements. You may opt out at any time.
© 2024 Blaze Media LLC. All rights reserved.
Get the stories that matter most delivered directly to your inbox.
By signing up, you agree to our Privacy Policy and Terms of Use, and agree to receive content that may sometimes include advertisements. You may opt out at any time.